Sou Hu Cai Jing·2025-09-13 18:01Core Viewpoint - Fosun Pharma's stock price has increased by 4.41% to 31.52 CNY as of September 12, 2025, with a market capitalization of 84.439 billion CNY, ranking 4th in the chemical pharmaceutical sector and 196th in the A-share market [1][2]. Company Announcement Summary - Fosun Pharma has provided guarantees for its subsidiaries, totaling 2.5 million USD and 1.226 billion CNY, which are within the previously estimated limits [1][2]. - As of September 12, 2025, the actual external guarantee balance of the group is approximately 23.6024 billion CNY, accounting for 49.94% of the audited net assets as of the end of 2024, with no overdue guarantees [1][2]. - The guarantees have been executed following internal decision-making procedures and do not require further approval [2].